---
{"dg-publish":true,"permalink":"/USMLE/Psychiatry/Drug addiction and dependence/","tags":["t1"]}
---

# Psychiatry medications
---
1. **[[USMLE/Psychiatry/Sedative-hypnotic drugs\|Benzodiazepines]] (-azepam, -azolam):**
    
    - **Mechanism:** Increase _frequency_ of GABAA​ Cl- channel opening.
    - **Risk:** High tolerance, physical dependence, abuse.
    - **Withdrawal:** Life-threatening (anxiety, [[USMLE/Psychiatry/Insomnia disorder\|insomnia]], **[[USMLE/Neurology/Seizures and epilepsy\|seizures]]**). Requires slow taper.
    - **Antidote (Overdose):** Flumazenil (can precipitate withdrawal).
2. **Barbiturates (-barbital):**
    
    - **Mechanism:** Increase _duration_ of GABAA​ Cl- channel opening.
    - **Risk:** Very high dependence, abuse, narrow therapeutic index (respiratory depression).
    - **Withdrawal:** Life-threatening (like BZDs, potentially worse).
3. **Stimulants (Methylphenidate, Amphetamines):**
    
    - **Mechanism:** Increase [[USMLE/Neurology/Neurotransmitters\|Dopamine]] (DA) / [[USMLE/Neurology/Neurotransmitters\|Norepinephrine]] (NE).
    - **Risk:** High abuse potential, psychological dependence.
    - **Withdrawal:** Significant but not typically life-threatening ("crash" - depression, fatigue, hypersomnia).
4. **Z-drugs (Zolpidem, Zaleplon, Eszopiclone):**
    
    - **Mechanism:** Selective GABAA​ (alpha-1) agonists.
    - **Risk:** Lower than BZDs, but tolerance, dependence, and withdrawal can occur.
    - **Use:** [[USMLE/Psychiatry/Insomnia disorder\|Insomnia]].

**Key Distinction:**

- **Antidepressant Discontinuation Syndrome (SSRIs/SNRIs):** Abrupt stop causes flu-like symptoms, insomnia, sensory issues ("FINISH"). _Not_ true dependence/addiction. Requires tapering.
